Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients
The novel coronavirus severe acute respiratory syndrome-CoV-2 (SARS-CoV-2) is responsible for COVID-19 infection. The COVID-19 pandemic represents one of the worst global threats in the 21st century since World War II. This pandemic has led to a worldwide economic recession and crisis due to lockdow...
Main Authors: | Alok Raghav, Zeeshan Ahmad Khan, Viabhav Kumar Upadhayay, Prashant Tripathi, Kirti Amresh Gautam, Brijesh Kumar Mishra, Jamal Ahmad, Goo-Bo Jeong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/3/587 |
Similar Items
-
Unveiling the promise: Exosomes as game‐changers in anti‐infective therapy
by: Vivek P. Chavda, et al.
Published: (2024-10-01) -
Exosomes in nanomedicine: a promising cell-free therapeutic intervention in burn wounds
by: Tasaduq Manzoor, et al.
Published: (2024-10-01) -
Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy
by: Yating Wu, et al.
Published: (2024-05-01) -
Advances in the discovery of exosome inhibitors in cancer
by: Huarui Zhang, et al.
Published: (2020-01-01) -
Comprehensive proteomic analysis of exosome mimetic vesicles and exosomes derived from human umbilical cord mesenchymal stem cells
by: Zhaoxia Zhang, et al.
Published: (2022-07-01)